Mps Limited · NSE:MPSLTD
Mps — Q1 FY27 Earnings Presentation
13 slides from Mps's earnings presentation
Slide 1: Earnings Presentation Q1 FY27
EARNINGS PRESENTATION Earnings Presentation Q1 FY27 Q1 FY27 www.mpslimited.com MPS Limited | 1
Slide 2: Disclaimer
DISCLAIMER This presentation contains forward-looking statements, inter-alia, to enable investors to comprehend Company’s prospects and take informed investment decisions. This report and other statements – written and oral – that we periodically make, contain forward-looking statements that set out
Slide 3: Financial Performance Q1 FY27
FINANCIAL PERFORMANCE Q1 FY27 www.mpslimited.com MPS Limited | 3
Slide 4: Highlights: Record Q1 Revenue, EBITDA, and PAT
HIGHLIGHTS: RECORD Q1 REVENUE, EBITDA, AND PAT The strongest opening quarter in our history that made MPS a Rule of 50 company REPORTED REVENUE RESEARCH SOLUTIONS w/o AJE Q1 FY27, YoY Q1 FY27, YoY +20.38% +26.33% Strongest Q1 in MPS history. INR 22,424 Lakhs (Q1FY27) vs INR 18,628 The 26.33% YoY ex-
Slide 5: Q1 Performance: Record Revenue, EBITDA and EPS Growth
Q1 PERFORMANCE: RECORD REVENUE, EBITDA AND EPS GROWTH Metrics Q1 FY27 Q1 FY26 YoY Var% Q4 FY26 QoQ Var% Reported Revenue (INR Lakhs) 22,424 18,628 20.38% 20,516 9.30% EBITDA (INR Lakhs) 7,696 5,029 53.03% 6,751 14.00% PAT (INR Lakhs) 5,039 3,524 42.99% 4,704 7.12% EBITDA (%) 34.32% 27.00% 7.32% 32.9
Slide 6: Excl. AJE: Faster Growth with Expanded Margins
EXCL. AJE: FASTER GROWTH WITH EXPANDED MARGINS Metrics Q1 FY27 Q1 FY26 Variance YoY Q4 FY26 Variance QoQ Reported Revenue (INR Lakhs) 19,847 15,459 28.38% 17,724 11.98% EBITDA (INR Lakhs) 6,695 4,277 56.53% 5,547 20.70% EBITDA (%) 33.73% 27.67% 6.06% 31.30% 2.43% Headcount 3,253 3,137 3.70% 3,146 3.
Slide 7: Research Financials: Scale and Margin, Moving Together
RESEARCH FINANCIALS: SCALE AND MARGIN, MOVING TOGETHER Q1 FY27 Q1 FY26 Variance YoY Q4 FY26 Variance QoQ Metrics WITH WITHOUT WITH WITHOUT WITH WITHOUT WITHOUT WITHOUT WITH AJE WITH AJE AJE AJE AJE AJE AJE AJE AJE AJE Revenue (INR Lakhs) 12,323 9,746 10,884 7,715 13.22% 26.33% 11,955 9,164 3.08% 6.3
Slide 8: Education Financials: Key Pillar Delivering at Scale
EDUCATION FINANCIALS: KEY PILLAR DELIVERING AT SCALE Metrics Q1 FY27 Q1 FY26 Variance YoY Q4F Y26 Variance QoQ Revenue (INR Lakhs) 7,341 5,162 42.21% 6,013 22.09% EBITDA (INR Lakhs) 2,574 1,850 39.14% 2,311 11.38% EBITDA (%) 35.06% 35.84% -0.78% 38.43% -3.37% Headcount 765 799 -4.26% 762 0.39% Educa
Slide 9: Corporate Learning Financials: Leaner Base, Stronger Returns
CORPORATE LEARNING FINANCIALS: LEANER BASE, STRONGER RETURNS Metrics Q1 FY27 Q1 FY26 Variance YoY Q4FY26 Variance QoQ Revenue (INR Lakhs) 2,760 2,582 6.89% 2,548 8.32% EBITDA (INR Lakhs) 699 435 60.69% 670 4.33% EBITDA (%) 25.33% 16.85% 8.48% 26.30% -0.97% Headcount 135 202 -33.17% 142 -4.93% Second
Slide 10: Revenue Mix: Diversification Through Growth
REVENUE MIX: DIVERSIFICATION THROUGH GROWTH Research Education Corporate Learning Q1FY27 55.0% 32.7% 12.3% Education stands as a genuine second pillar. Unbound Medicine adds to the quality further, anchoring it in recurring, Q4FY26 58.3% 29.3% 12.4% high-renewal subscription revenue. Q3FY26 63.3% 24
Slide 11: Diversification: A Sustained Strategic Focus
DIVERSIFICATION: A SUSTAINED STRATEGIC FOCUS Metrics Q1 FY27 Q1 FY26 Q4 FY26 North America 49% 51% 52% Revenue by Geography Europe 33% 29% 33% Rest of the World 18% 20% 15% Debtors DSO (Days) 45 45 51 No. of clients billed 841 404 906 Client Top 5 contribution 46% 45% 45% Diversification Top 10 cont
Slide 12: FY27: Tracking to Comfortably Cross INR 300 Crores in EBITDA
FY27: TRACKING TO COMFORTBALY CROSS INR 300 CRORES IN EBITDA INR 300+ Cr FY27 EBITDA GUIDANCE, REITERATED ~21% three-year EBITDA CAGR (FY24 to FY27), built bottom-up from each segment operating plan Q1 landed ahead of a straight-line path, and our second half has historically outrun our first. We co
Slide 13: Thank You
THANK YOU www.mpslimited.com MPS Limited | 13